Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study
Background: Percutaneous coronary intervention (PCI) is the most common revascularization procedure, with over 1 million performed each year, worldwide. Over the past 20 years, the increasing experience of operators coupled with the advent of newer technologies, including coronary stents and a var...
Main Authors: | Hossein Farshidi, Ahmadnoor Abdi, Abdulhussain Madani, Shahram Moshiri, Abolfazl Ghasemi, Ruhollah Hakimian |
---|---|
Format: | Article |
Language: | English |
Published: |
Electronic Physician
2018-02-01
|
Series: | Electronic Physician |
Subjects: | |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878034/ |
Similar Items
-
GRACE, SYNTAX I and SYNTAX II scores as predictors of one-year MACE outcome in patients with myocardial infarction treated with percutaneous coronary intervention
by: Davidović Aleksandar, et al.
Published: (2022-01-01) -
PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction
by: Wu ZF, et al.
Published: (2023-08-01) -
Predictive Model for Long-term Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
by: Qin LI, Xin TAN, Wenxi JIANG, Meng YUAN, Hui NI, Yuan WANG, Jie DU
Published: (2022-08-01) -
Effect of Ticagrelor Compared to Clopidogrel on Short-term Outcomes of COVID-19 Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention; a Randomized Clinical Trial
by: Reza Arefizadeh, et al.
Published: (2023-01-01) -
Percutaneous coronary intervention in a patient with single coronary artery
by: T.K. Mishra, et al.
Published: (2014-05-01)